Bicycle Therapeutics plc Shareholders' Equity
Bicycle Therapeutics plc (BCYC) had Shareholders' Equity of $510.25 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-30
- 2026-06-30: Stockholders' Equity Attributable to Parent $510.25M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $554.32M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $609.98M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $618.48M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $510.25M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $554.32M 10-Q · filed 2026-07-30 |
| 2025-12-31 | $609.98M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $618.48M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $668.91M 10-Q · filed 2026-07-30 |
| 2025-03-31 | $740.33M 10-Q · filed 2026-07-30 |
| 2024-12-31 | $793.06M 10-Q · filed 2026-07-30 |
| 2024-09-30 | $831.03M 10-Q · filed 2025-10-30 |
| 2024-06-30 | $873.81M 10-Q · filed 2025-10-30 |
| 2024-03-31 | $356.05M 10-Q · filed 2025-10-30 |
| 2023-12-31 | $370.93M 10-K · filed 2026-03-17 |
| 2023-09-30 | $416.02M 10-Q · filed 2024-10-31 |
| 2023-06-30 | $220.10M 10-Q · filed 2024-10-31 |
| 2023-03-31 | $243.16M 10-Q · filed 2024-10-31 |
| 2022-12-31 | $270.78M 10-K · filed 2026-03-17 |
| 2022-09-30 | $289.47M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $311.39M 10-Q · filed 2023-11-02 |
| 2022-03-31 | $330.26M 10-Q · filed 2023-11-02 |
| 2021-12-31 | $346.25M 10-K · filed 2025-02-25 |
| 2021-09-30 | $170.82M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $142.05M 10-Q · filed 2022-11-03 |
| 2021-03-31 | $142.09M 10-Q · filed 2022-11-03 |
| 2020-12-31 | $95.46M 10-K · filed 2024-02-20 |
| 2020-09-30 | $109.55M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $71.03M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $81.81M 10-Q · filed 2021-11-04 |
| 2019-12-31 | $93.20M 10-K · filed 2023-02-28 |
| 2019-09-30 | $95.33M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $104.56M 10-Q · filed 2020-11-05 |
| 2019-03-31 | -$74.97M 10-Q · filed 2020-11-05 |
| 2018-12-31 | -$69.83M 10-K · filed 2022-03-01 |
| 2018-09-30 | -$62.97M 10-Q · filed 2019-11-07 |
| 2018-06-30 | -$54.97M 10-Q · filed 2019-11-07 |
| 2018-03-31 | -$47.67M 10-Q · filed 2019-11-07 |
| 2017-12-31 | -$47.18M 10-K · filed 2021-03-11 |
| 2016-12-31 | -$33.80M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |